- Home
- IMCR vs SAH Comparison
IMCR vs SAH Comparison
Compare IMCR & SAH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMCR
- SAH
- Stock Information
- Founded
- IMCR 2008
- SAH 1997
- Country
- IMCR United Kingdom
- SAH United States
- Employees
- IMCR N/A
- SAH N/A
- Industry
- IMCR Biotechnology: Biological Products (No Diagnostic Substances)
- SAH Other Specialty Stores
- Sector
- IMCR Health Care
- SAH Consumer Discretionary
- Exchange
- IMCR Nasdaq
- SAH Nasdaq
- Market Cap
- IMCR 1.5B
- SAH 2.5B
- IPO Year
- IMCR 2021
- SAH 1997
- Fundamental
- Price
- IMCR $32.80
- SAH $87.57
- Analyst Decision
- IMCR Buy
- SAH Strong Buy
- Analyst Count
- IMCR 10
- SAH 8
- Target Price
- IMCR $58.13
- SAH $74.63
- AVG Volume (30 Days)
- IMCR 444.9K
- SAH 188.0K
- Earning Date
- IMCR 08-07-2025
- SAH 08-04-2025
- Dividend Yield
- IMCR N/A
- SAH 1.60%
- EPS Growth
- IMCR N/A
- SAH 43.80
- EPS
- IMCR N/A
- SAH 7.02
- Revenue
- IMCR $333,581,000.00
- SAH $14,491,600,000.00
- Revenue This Year
- IMCR $26.82
- SAH $4.55
- Revenue Next Year
- IMCR $8.15
- SAH $3.44
- P/E Ratio
- IMCR N/A
- SAH $12.48
- Revenue Growth
- IMCR 25.75
- SAH 1.59
- 52 Week Low
- IMCR $23.15
- SAH $51.27
- 52 Week High
- IMCR $41.54
- SAH $88.03
- Technical
- Relative Strength Index (RSI)
- IMCR 51.47
- SAH 79.51
- Support Level
- IMCR $30.76
- SAH $79.07
- Resistance Level
- IMCR $33.95
- SAH $82.53
- Average True Range (ATR)
- IMCR 1.39
- SAH 2.01
- MACD
- IMCR -0.15
- SAH 0.44
- Stochastic Oscillator
- IMCR 43.05
- SAH 98.83
About IMCR Immunocore Holdings plc
Immunocore Holdings PLC is a commercial-stage biotechnology company. Using its ImmTAX platform, the company is developing a deep pipeline in multiple therapeutic areas, including clinical stage programs in oncology and infectious disease, pre-clinical programs in autoimmune disease, and earlier pre-clinical programs across three therapeutic areas. The company's main product, KIMMTRAK, is used for the treatment of unresectable or metastatic uveal melanoma (mUM). The other drug candidates in its pipeline include Brenetafusp, IMC-P115C, IMC-T119C, IMC-R117C, IMC-S118AI, IMC-U120AI, and others, being developed as a potential treatment for various oncology, infectious, and autoimmune diseases.
About SAH Sonic Automotive Inc.
Sonic Automotive is one of the largest auto dealership groups in the United States. The company has 108 franchised stores in 18 states, primarily in metropolitan areas in California, Texas, and the Southeast, plus 18 EchoPark used-vehicle stores, 16 collision centers, and 15 powersports locations. The franchise stores derive revenue from new and used vehicles plus parts and collision repair, finance, insurance, and wholesale auctions. Luxury and import dealerships make up about 86% of franchise new-vehicle revenue, while Honda, BMW, Mercedes, and Toyota constitute about 59% of new-vehicle revenue. BMW is the largest brand at about 25%. 2024's revenue was $14.2 billion, with Texas and California comprising 51% of the total. EchoPark's portion was $2.1 billion.